IDEAS home Printed from https://ideas.repec.org/a/nat/nature/v563y2018i7731d10.1038_s41586-018-0506-3.html
   My bibliography  Save this article

Publisher Correction: Suppression of insulin feedback enhances the efficacy of PI3K inhibitors

Author

Listed:
  • Benjamin D. Hopkins

    (Meyer Cancer Center, Weill Cornell Medicine)

  • Chantal Pauli

    (University Hospital Zurich
    Englander Institute for Precision Medicine, Weill Cornell Medicine-New York Presbyterian Hospital)

  • Xing Du

    (Columbia University Medical Center and New York Presbyterian Hospital)

  • Diana G. Wang

    (Meyer Cancer Center, Weill Cornell Medicine
    Weill Cornell Medicine/Rockefeller University/Sloan Kettering Tri-Institutional MD-PhD Program)

  • Xiang Li

    (Weill Cornell Graduate School of Medical Sciences)

  • David Wu

    (Meyer Cancer Center, Weill Cornell Medicine)

  • Solomon C. Amadiume

    (Meyer Cancer Center, Weill Cornell Medicine)

  • Marcus D. Goncalves

    (Meyer Cancer Center, Weill Cornell Medicine
    Weill Cornell Medicine)

  • Cindy Hodakoski

    (Meyer Cancer Center, Weill Cornell Medicine)

  • Mark R. Lundquist

    (Meyer Cancer Center, Weill Cornell Medicine)

  • Rohan Bareja

    (Meyer Cancer Center, Weill Cornell Medicine
    Englander Institute for Precision Medicine, Weill Cornell Medicine-New York Presbyterian Hospital
    Weill Cornell Medicine)

  • Yan Ma

    (Columbia University Medical Center and New York Presbyterian Hospital)

  • Emily M. Harris

    (Columbia University Medical Center and New York Presbyterian Hospital)

  • Andrea Sboner

    (Meyer Cancer Center, Weill Cornell Medicine
    Englander Institute for Precision Medicine, Weill Cornell Medicine-New York Presbyterian Hospital
    Weill Cornell Medicine
    Weill Cornell Medicine)

  • Himisha Beltran

    (Meyer Cancer Center, Weill Cornell Medicine
    Englander Institute for Precision Medicine, Weill Cornell Medicine-New York Presbyterian Hospital
    Weill Cornell Medicine)

  • Mark A. Rubin

    (Englander Institute for Precision Medicine, Weill Cornell Medicine-New York Presbyterian Hospital
    , University of Bern and the Inselspital)

  • Siddhartha Mukherjee

    (Columbia University Medical Center and New York Presbyterian Hospital)

  • Lewis C. Cantley

    (Meyer Cancer Center, Weill Cornell Medicine)

Abstract

In this Letter, author Xing Du was incorrectly listed as Du Xing; this has been corrected online.

Suggested Citation

  • Benjamin D. Hopkins & Chantal Pauli & Xing Du & Diana G. Wang & Xiang Li & David Wu & Solomon C. Amadiume & Marcus D. Goncalves & Cindy Hodakoski & Mark R. Lundquist & Rohan Bareja & Yan Ma & Emily M., 2018. "Publisher Correction: Suppression of insulin feedback enhances the efficacy of PI3K inhibitors," Nature, Nature, vol. 563(7731), pages 24-24, November.
    • Handle: RePEc:nat:nature:v:563:y:2018:i:7731:d:10.1038_s41586-018-0506-3
    DOI: 10.1038/s41586-018-0506-3
    as

    Download full text from publisher

    File URL: https://www.nature.com/articles/s41586-018-0506-3
    File Function: Abstract
    Download Restriction: Access to the full text of the articles in this series is restricted.
    File URL: https://libkey.io/10.1038/s41586-018-0506-3?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    As the access to this document is restricted, you may want to search for a different version of it.

    Citations

    Citations are extracted by the CitEc Project, subscribe to its RSS feed for this item.
    as


    Cited by:

    1. Ziwei Dai & Weiyan Zheng & Jason W. Locasale, 2022. "Amino acid variability, tradeoffs and optimality in human diet," Nature Communications, Nature, vol. 13(1), pages 1-13, December.
    2. Xiao-Li Wei & Fu-Rong Liu & Ji-Hong Liu & Hong-Yun Zhao & Yang Zhang & Zhi-Qiang Wang & Miao-Zhen Qiu & Fei Xu & Qiu-Qiong Yu & Yi-Wu Du & Yan-Xia Shi & De-Sheng Wang & Feng-Hua Wang & Rui-Hua Xu, 2022. "First-in-human phase Ia study of the PI3Kα inhibitor CYH33 in patients with solid tumors," Nature Communications, Nature, vol. 13(1), pages 1-10, December.

    More about this item

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:nature:v:563:y:2018:i:7731:d:10.1038_s41586-018-0506-3. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    We have no bibliographic references for this item. You can help adding them by using this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.